HIV-1 infection remains a major public health problem, with an estimated 38.4 million people living with HIV and 1.5 million new HIV infections reported worldwide in 2021. The risk of HIV infection ...
A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, USA, ...
Oral HIV pre-exposure prophylaxis (PrEP) is highly effective for preventing HIV. Several different developments in the US either threaten to increase or promise to decrease PrEP out-of-pocket costs ...
Elizabeth M. Stone ([email protected]), Rutgers University, New Brunswick, New Jersey. Nicholas J. Seewald, University of Pennsylvania, Philadelphia, Pennsylvania ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results